Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. - Wikidata - wikimedia - TriplyDB

Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.

Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q35537515

about

Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis Inhaled corticosteroids for stable chronic obstructive pulmonary disease Inhaled corticosteroids for stable chronic obstructive pulmonary disease Identification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysis The asthma-COPD overlap syndrome: do we really need another syndrome in the already complex matrix of airway disease?Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease Cough and its importance in COPD Sputum proteomics in inflammatory and suppurative respiratory diseases Sputum myeloperoxidase in chronic obstructive pulmonary disease.Blood and sputum eosinophils in COPD; relationship with bacterial load.Asthma and chronic obstructive pulmonary disease Airways disease: phenotyping heterogeneity using measures of airway inflammation.COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils.Reference ranges for induced sputum eosinophil counts in Korean adult population.Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.Immunological Features of Chronic Obstructive Pulmonary Disease (COPD) Induced by Indoor Pollution and Cigarette Smoke Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD.Repeatability of exhaled nitric oxide measurements in patients with COPD Novel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations.Biological clustering supports both "Dutch" and "British" hypotheses of asthma and chronic obstructive pulmonary disease.Design of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?The role of CT scanning in multidimensional phenotyping of COPD.Managing the safety of inhaled corticosteroids in COPD and the risk of pneumonia.Prediction of Long-Term Benefits of Inhaled Steroids by Phenotypic Markers in Moderate-to-Severe COPD: A Randomized Controlled Trial Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma.The effects of corticosteroids on COPD lung macrophages: a pooled analysis Is a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome in a patient with COPD?Inflammatory cells in the airways in COPD.COPD: it is time to change!Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial.Association of blood eosinophils and plasma periostin with FEV1 response after 3-month inhaled corticosteroid and long-acting beta2-agonist treatment in stable COPD patients.Pulmonary biomarkers in chronic obstructive pulmonary disease.Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional study A challenge to the seven widely believed concepts of COPD.Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.

P2860

Q24197853-5950E44D-92DB-4821-BFAA-76FAD0C6F56D Q24202092-21735712-525A-4825-B4A6-B0796B81BCC9 Q24245481-B0450405-E3C2-4E2D-9731-191F50262824 Q24658537-97F02113-E58D-4F1C-B81D-8800F8F89CCC Q26745760-963473EB-0F8F-4AD2-B76D-0CBB25E96BC6 Q26771819-61275275-61C5-47AC-A2A9-54C089C503B9 Q26801661-5ACB139E-C7F9-4C18-B813-63418553F682 Q28070274-EB97268B-ED38-4B39-9C55-3449DED2D1C7 Q28761895-E02AB352-3B63-469D-A487-5467833F014F Q30488037-9A482E96-09C3-4CFB-BC50-9468C52BEDD0 Q33345110-8A01F006-041E-4655-9ED4-5E74536899AD Q33592946-A45C38FD-4351-4320-ADB6-25E10BA6C0B8 Q33651114-058536F7-1C9E-4E66-9A36-CC654C9928BC Q33706788-6D323E1E-B056-4C9F-807A-296187CD05C2 Q33864952-0397618B-1BC9-47D5-AF3E-83011A020CF4 Q33970269-74FAA9CC-32B5-40A5-BE18-DFBB6C27DAD0 Q33974508-67B33ED2-E398-4E04-8970-2809C25AE12A Q34065276-AA03CBC4-2C60-42BF-9E51-21FA8D5BB774 Q34126693-7AC39858-189D-4CCD-A35D-F920AB268B7D Q34231310-371B3DF0-84D2-4584-9432-4519A41786F5 Q34275321-292135CD-0175-4CC4-9309-F34356E2E24D Q34619392-CD73B7D7-3671-4205-A91E-2F6990DF6352 Q34684239-D6DDBBD6-1660-4CBB-8002-6D72494B4F89 Q34808077-6F97C03C-5411-4DC3-B0CD-418B083501D6 Q35041299-9C87B7B3-0B30-45DD-AB4A-E8A0155395B7 Q35119108-71BBC6BF-BDDB-409E-9DF0-522A04E4B72A Q35201868-F094E1AE-BC0B-4A8F-8E26-A33A6C8030B1 Q35675040-CC2806CA-D6E8-44A2-9449-822CC13F6CEF Q35867300-B7FBAFCD-B03E-42CA-A29E-44D64AF9A919 Q35940249-32042A93-DF51-4379-BA5A-07812BF0C24F Q35985973-EA07FF4C-ED56-43CA-8F9C-B82DA4BF14B3 Q36036910-CED1A0A0-F37C-4FD8-924F-AF6B9AC34D36 Q36203075-39CE8043-9B3F-4876-9F0F-0A3644482A9C Q36288971-74A80545-F772-4CB1-A26B-7AD8F5D7E7BE Q36302882-15FCD250-245E-4BF6-A299-AEF3E09A7E3F Q36412702-0CBA871E-360A-4A5E-92E3-36BA52D4161E Q36429908-FB554E7A-186B-4684-BE7E-74A7E699B79C Q36444783-FC87DA4E-8D7C-420A-948A-C63BBFBC67E0 Q36558218-4F7614F3-574F-483F-A477-9503C12B15A9 Q36907742-948E0D93-B04A-4697-828D-084C449FB9B2

P2860

Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q35537515

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Sputum eosinophilia and the sh ...... obstructive pulmonary disease.

@ast

Sputum eosinophilia and the sh ...... obstructive pulmonary disease.

@en

type

label

Sputum eosinophilia and the sh ...... obstructive pulmonary disease.

@ast

Sputum eosinophilia and the sh ...... obstructive pulmonary disease.

@en

prefLabel

Sputum eosinophilia and the sh ...... obstructive pulmonary disease.

@ast

Sputum eosinophilia and the sh ...... obstructive pulmonary disease.

@en

P1433

Q35537515-AB5A8F1D-4B53-4E13-9EA6-57D8BF7F29A8

P1476

Q35537515-4F9CBBE7-9761-4EC0-A9E0-7FA9DF78AA9D

P2093

Q35537515-0B62F181-3B64-46D9-BCDB-04BBD9373999

Q35537515-56E844DE-EAD9-4EBB-9C3D-3AD4DDBF6D13

Q35537515-65F29065-5F8A-4E0E-8A06-3CB10CA916A2

Q35537515-7B92F504-F5A4-46AF-91BC-DA64E5DE613D

Q35537515-81819B88-8C96-407A-A52E-1D8C2C64EB1E

Q35537515-91DED641-EBD6-48BE-9E25-6FBA0BF7CCB2

Q35537515-A2A447A8-8D2A-4185-8856-8D002B85E7DA

Q35537515-E5F844D5-D303-4EBD-8F17-550FC1794345

P2860

Q35537515-0DCE859E-5861-4D44-BDB8-6B62D534F558

Q35537515-0F5834EB-45D3-436A-A009-4BFE4CBFA874

Q35537515-27FA2C70-20E9-430A-B46B-99CCDDFC2833

Q35537515-2966A607-DFE7-42E3-97DA-92F7C3458389

Q35537515-45F8435C-155A-414D-BF1B-6A06FC67B05D

Q35537515-61D6E95E-E307-4FA4-B985-9FE9B190726E

Q35537515-7A9F3B7E-50CD-4DCD-9BCF-0F61DBB0F2E9

Q35537515-945839A9-B76A-47E6-8B20-B0B3167BA08F

Q35537515-A945E2E0-3DCF-45F3-8752-09D4420E5AB1

Q35537515-B423DFE6-CA1E-4903-9352-773BF10B8106

P304

Q35537515-9B58D062-6834-4477-B745-721029F2D539

P31

Q35537515-D64EC55F-66D1-4A24-A6FD-D3486FAD1320

P356

Q35537515-104C7784-C3E6-4B00-8DFA-EB8A1AC5F54B

P407

Q35537515-72063815-506B-42B3-95F7-E8D58DBB6B8D

P433

Q35537515-D4664FB2-0331-4F81-8340-C37885EF28D1

P478

Q35537515-4FC2C0D0-78CD-4BDE-B5AA-D6F17E226E94

P50

Q35537515-0DEF5EE5-B91C-4559-B109-07C27D64A5C3

Q35537515-3B4B4C52-4CE4-4584-B0CF-4CAEF1236798

Q35537515-B0EAAE11-3370-4822-909E-32F0E2D45CF3

P577

Q35537515-2D35F6C1-7827-48D1-9B9E-BFBF67E52C82

P5875

Q35537515-F6587FEA-4B66-452E-975D-EF8F8D0F0541

P698

Q35537515-48045887-45DB-4C6D-918C-919F14740445

P921

Q35537515-88B6E08E-8BF4-4F65-9B65-DAC30CC3A57C

Q35537515-E4C48B4A-D398-4C6D-8201-034E1F477D8E

P932

Q35537515-64490C7C-2717-4184-AACF-E63731E38C9A

P356

THX.2004.032516

P1433

P1476

Sputum eosinophilia and the sh ...... obstructive pulmonary disease

@en

P2093

Berry M

http://www.w3.org/2001/XMLSchema#string

Birring S

http://www.w3.org/2001/XMLSchema#string

Green R

http://www.w3.org/2001/XMLSchema#string

Hargadon B

http://www.w3.org/2001/XMLSchema#string

McKenna S

http://www.w3.org/2001/XMLSchema#string

Monteiro W

http://www.w3.org/2001/XMLSchema#string

Parker D

http://www.w3.org/2001/XMLSchema#string

Siva R

http://www.w3.org/2001/XMLSchema#string

P2860

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation.

Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease.

Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue.

Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study.

Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects.

Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis.

A measure of quality of life for clinical trials in chronic lung disease

Prednisolone response in patients with COPD.

P304

193-198

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.2004.032516

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

Chris Brightling

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7993342

http://www.w3.org/2001/XMLSchema#string

P698

15741434

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

1747331

http://www.w3.org/2001/XMLSchema#string